Sign in to view content

Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results

Karen M Wai, MD
STEPHEN J SMITH, MD

Video
Published 2025

Related

Comparison of Hypochlorous Acid vs. Povidone Iodine Use Prior to Intravitreal Injection: A Randomized Prospective Trial Study
Robert L. Avery, MD
Annual Meeting Talks
2021
PRISM Phase 2b Clinical Trial Evaluating Intravitreal 4D-150 in Adults With Neovascular Age-Related Macular Degeneration: 52-Week Results
John A. Wells, MD, FACS
Updates from the Field
2025
Optimization of the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure in the LADDER Phase 2 Trial
Mark R. Wieland, MD
Annual Meeting Talks
2019

Category: Pharmacology

See more